This page includes the latest FDA filings for Kymos S L. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
|---|---|---|
| CELLTRION Inc., BioReliance Ltd, WuXi Advanced Therapies, Inc, Samsung Biologics Co., Ltd., CELLTRION Pharm, Inc., Patheon Italia S.p.A., KYMOS, S.L., STERIPACK MEDICAL POLAND SP Z O O | Prescription Medication | 2024-12-28 |
| CELLTRION USA Inc., CELLTRION Inc., BioReliance Ltd., Wuxi Advanced Therapies, Inc., WuXi AppTec, Inc., SGS Vitrology Limited, VETTER Pharma-Fertigung GmbH & Co. KG, CELLTRION Pharm, Inc., KYMOS, S.L. | Prescription Medication | 2024-07-30 |
| CELLTRION USA Inc., CELLTRION Inc., BioReliance Ltd., Wuxi Advanced Therapies, Inc., WuXi AppTec, Inc., SGS Vitrology Limited, VETTER Pharma-Fertigung GmbH & Co. KG, CELLTRION Pharm, Inc., KYMOS, S.L. | Prescription Medication | 2024-05-04 |
| CELLTRION USA Inc., CELLTRION Inc., BioReliance Ltd., Wuxi Advanced Therapies, Inc., WuXi AppTec, Inc., SGS Vitrology Limited, VETTER Pharma-Fertigung GmbH & Co. KG, CELLTRION Pharm, Inc., KYMOS, S.L. | Prescription Medication | 2024-03-01 |